Medtronic plc
MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitorinā¦ read more
Healthcare
Medical Devices
53 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$86.44
Price+0.17%
$0.15
1Y
Price
Market Cap
$110.648b
Large
Price/Earnings 3y Avg5y Avg
15.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+20.0%
EBITDA Margin+15.1%
Net Profit Margin+13.2%
Free Cash Flow Margin+20.0%
EBITDA Margin+15.1%
Net Profit Margin+13.2%
Free Cash Flow MarginRevenue
$37.542b
+3.2%
1y CAGR+5.1%
3y CAGR+4.7%
5y CAGREarnings
$5.230b
+9.0%
1y CAGR+12.9%
3y CAGR+9.1%
5y CAGREPS
$4.06
+8.9%
1y CAGR+14.3%
3y CAGR+10.2%
5y CAGRBook Value
$50.850b
$93.306b
Assets$42.456b
Liabilities$28.153b
DebtDebt to Assets
30.2%
3x
Debt to EBITDAFree Cash Flow
$6.132b
+13.0%
1y CAGR+5.8%
3y CAGR+7.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company